Affiliation:
1. Department of Medicine, Division of Hematology-Oncology
2. Department of Paediatrics
3. Immunology Program of the Graduate School of Medical Sciences, Weill Medical College, Cornell University, New York, USA
Abstract
SUMMARY
Staphylococcal toxic shock syndrome (TSS) is an acute life threatening disease. The diagnosis can be made clinically based on diagnostic criteria. The clinical manifestations are caused in large part by the release of high levels of T-cell-derived cytokines as a result of potent toxins, also called superantigens (SAg), produced by Staphylococcus aureus, but it is not clear which clinical symptoms/signs are strictly T-cell dependent. Here, we report on three adults with multiple myeloma (MM) presenting with S. aureus sepsis/shock, and two patients with typical TSS. The MM patients had compromised humoral immunity because of depression of normal immunoglobulin (Ig) levels at the expense of the M protein. In addition, their T cells were absent due to high dose chemotherapy initiated for bone marrow transplantation. The MM cases lacked mucosal hyperemia, erythroderma and desquamation, but were otherwise indistinguishable from the TSS cases. All patients grew S. aureus and in each case, SAg genes were detected by PCR. In several cases, the plasma contained biological SAg activity resulting in Vβ specific proliferation of indicator T cells in vitro. The same specific activity was observed with the supernatant fluids of S. aureus broth cultures from the respective bacterial isolates. This confirms the presence of bio-active toxins in the plasma but did not lead to full blown TSS when T cells were lacking. Thus, S. aureus sepsis/shock can be clinically distinguished from typical TSS, and we suggest that muco-cutaneous manifestations of TSS are the most telling signs of massive T-cell-dependent cytokine release.
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Reference43 articles.
1. Case definitions for public health surveillance. Toxic shock syndrome;Anon;MMWR,1990
2. Toxic shock syndrome in the United States: surveillance update, 1979–1996;Hajjeh;Emerg Infect Dis,1999
3. Active surveillance for Toxic Shock Syndrome in the United States, 1986;Gaventa;Rev Infect Dis,1989
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献